Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

Journal of Neuro-Oncology

Volumn 51, Issue 2, 2001, Pages 159-165

  Schagen, Sanne B ^a   Hamburger, Hans L ^a   Muller, Martin J ^a   Boogerd, Willem ^a   Van Dam, Frits S A M ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Breast cancer; Chemotherapy; Cognitive impairment; ERP; Late effects; qEEG

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; THIOTEPA;

ALPHA RHYTHM; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DELAYED NEUROTOXICITY; DRUG EFFECT; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; EVALUATION; EVENT RELATED POTENTIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MENTAL PERFORMANCE; MULTIMODALITY CANCER THERAPY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL;

ALPHA RHYTHM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; BREAST NEOPLASMS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; COGNITION; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; DEPRESSION; ELECTROENCEPHALOGRAPHY; EPIRUBICIN; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; FATIGUE; FLUOROURACIL; HUMANS; INTELLIGENCE; LEAST-SQUARES ANALYSIS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; THIOTEPA;

EID: 0035041327     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010635229762     Document Type: Article

References (21)

1. Rodenhuis S, Huitema AD, van Dam FS, de Vries EG, Beijnen JH: High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer. Cancer J Sci Am 6: 125-130, 2000
2. van Dam FS, Schagen SB, Muller MJ, Boogerd W, v d Wall E, Droogleever Fortuyn ME, Rodenhuis S: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 4: 210-218, 1998
3. Dropcho EJ: Central nervous system injury by therapeutic irradiation. Ed. Neurologic Complications of Systemic Cancer. Neurol Clin 9: 969-988, 1991
4. Roman DD, Sperduto PW: Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 31: 983-998, 1995
5. Boogerd W. Neurological complications of chemotherapy. In: Vinken, Bruyn “eds” Handbook of Clinical Neurology: Intoxications of the Nervous System. Part II. Elsevier Science, Amsterdam, 1995, pp 527-546
6. De Angelis LM, Shapiro WR: Drug/radiation interactions and central nervous system injury. In: Gutin PH, Leibel SA, Sheline GE “eds” Radiation Injury of the Nervous System. Raven Press, New York, 1991, pp 361-382
7. Meyers CA: Neurocognitive dysfunction in cancer patients. Oncology 14“1”: 75-79, 2000
8. Bio-logic System Corp. Brain Atlas III, Mundelein, Illinios
9. Hamburger HL, Brugt v d MAG: Global field power measurement versus classical method in the determination of the latency of evoked potential components. Brain Topography 3: 391-396, 1991
10. de Jonghe F, Huyser J, Swinkels J, Sno H, Schalken H: Depressie en Angstlijst, 1990
11. Aaronson NK, Ahmedzi S, Bergman B, Bullinger M, Cull A: The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376, 1993
12. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L: Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30a: 37-40, 1994
13. SPSS Benelux B.V. Gorichem, The Netherlands.
14. Schmand B, Lindeboom J, van Harskamp F: De Nederlandse Leestest voor Volwassenen. Swets & Zeitlinger, Lisse, 1992
15. Meyers CA, Abbruzzese JL: Cognitive functioning in cancer patients: effect of previous treatment. Neurology 42“2”: 434-436, 1992
16. Van Oosterhout AG, Ganzevles PG, Wilmink JT, De Geus BW, Van Vonderen RG, Twijnstra A: Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 34 “5”: 1037-1044, 1996
17. Stemmer SM, Stears JC, Burton BS, Jones RB, Simon JH: White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. Am J Neuroradiol 15“7”: 1267-1273, 1994
18. Brown MS, Stemmer SM, Simon JH, Stears JC, Jones RB, Cagnoni PJ, Sheeder JL: White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. Am J Neuroradiol 19“2”: 217-221, 1998
19. Jonkman EJ, van Huffelen AC, Pfurtscheller G: Quantitative EEG and cerebral ischemia. In: Lopes da Silva FH, Storm van Leeuwen W, Remond A “eds” Handbook of Electroencephalography and Clinical Neurophysiology. Elsevier, Amsterdam, 1986, pp 205-237
20. Viggiano MP: Event-related potentials in brain-injured patients with neuropsychological disorders: a review. J Clin Exp Neuropsychol 18“5”: 631-647, 1996
21. Cohen RA, O'Donnell BF, Meadows ME, Moonis M, Stone WF, Drachman DA: ERP indices and neuropsychological performance as predictors of functional outcome in dementia. J Geriatr Psychiatry Neurol 8“4”: 217-225, 1995